Martin Turner studied Biochemistry at UCL and did his PhD with Professor Sir Marc Feldmann in London. He worked with Victor Tybulewicz at the MRC National Institute for Medical Research where he identified key signal transduction pathways for B and T lymphocytes. He has been at the BBSRC’s Babraham Institute since 1997. He has uncovered key roles for PI3K in lymphocyte signalling and development. He is interested in RNA-binding proteins and MicroRNAs and how these function within signal transduction networks and DNA transcription factor networks to control cell differentiation and immunity.